Oxford Gene Technology Receives $3.6M for Clinical Research Using Sequencing | GenomeWeb

NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has been awarded two grants totaling €3 million ($3.6 million) to provide genomic analysis and commercialization services for two international studies.

In one study, called EUCLIDS (EU Life-threatening Infectious Disease Study), OGT will use a five-year, €1.1 million grant to perform high-throughput genomic analysis for the identification of genomic variants that determine susceptibility and severity of life-threatening bacterial infections in children. These include meningococcal and pneumococcal cohorts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.